Trials / Completed
CompletedNCT00888381
A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers
A Phase IV, Single-centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2009/2010 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged ≥ 18 to < 60 Years) and 'Older Adults' (Aged ≥ 60 Years).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the efficacy and safety of CSL's 2009/2010 formulation of the Enzira vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Inactivated Influenza Vaccine (2009 / 2010 formulation) | A single 0.5mL intramuscular injection into the deltoid region of the arm on Day 0. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2009-04-27
- Last updated
- 2018-06-28
- Results posted
- 2012-07-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00888381. Inclusion in this directory is not an endorsement.